Literature DB >> 22579685

The in vitro inhibition effect of 2 nm gold nanoparticles on non-enzymatic glycation of human serum albumin.

Champika Seneviratne1, Radha Narayanan, W Liu, J A Dain.   

Abstract

The reaction of amino groups of protein and the carbonyl groups of reducing sugar molecules, non-enzymatically induce a series of chemical reactions that form a heterogeneous group of compounds known as advanced glycation end products (AGEs). The accumulation of AGEs is associated with various disease conditions that include complications in diabetes, Alzheimer's disease and aging. The current study monitored the extent of non-enzymatic glycation of human serum albumin (HSA) in order to estimate the formation of HSA related AGEs in the presence of 2 nm gold nanoparticles. The rate of glycation was evaluated using several analytical methods. Physiological concentrations of HSA and glyceraldehyde mixtures, incubated with various concentrations of negatively charged 2 nm gold nanoparticles, resulted in a lower reaction rate than mixtures without 2GNP. Moreover, increasing concentrations of gold nanoparticles exhibited a pronounced reduction in AGE formation. High performance liquid chromatography, UV-visible spectroscopy and circular dichroism analytical methods provide reliable techniques for evaluating AGE formation of HSA adducts.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22579685     DOI: 10.1016/j.bbrc.2012.05.014

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

1.  Modulated Protein Binding Ability of Anti-Diabetic Drugs in Presence of Monodispersed Gold Nanoparticles and its Inhibitory Potential towards Advanced Glycated End (AGE) Product Formation.

Authors:  Imocha Rajkumar Singh; Sivaprasad Mitra
Journal:  J Fluoresc       Date:  2020-01-10       Impact factor: 2.217

2.  Amadori glycated proteins: role in production of autoantibodies in diabetes mellitus and effect of inhibitors on non-enzymatic glycation.

Authors:  Nadeem A Ansari; Debabrata Dash
Journal:  Aging Dis       Date:  2012-12-10       Impact factor: 6.745

3.  Gold Nanoparticle-Bioconjugated Aminoguanidine Inhibits Glycation Reaction: An In Vivo Study in a Diabetic Animal Model.

Authors:  Saheem Ahmad; Mohd Sajid Khan; Sultan Alouffi; Saif Khan; Mahvish Khan; Rihab Akashah; Mohammad Faisal; Uzma Shahab
Journal:  Biomed Res Int       Date:  2021-05-12       Impact factor: 3.411

4.  Inhibitory effect of gold nanoparticles on the D-ribose glycation of bovine serum albumin.

Authors:  Weixi Liu; Menashi A Cohenford; Leslie Frost; Champika Seneviratne; Joel A Dain
Journal:  Int J Nanomedicine       Date:  2014-11-26

Review 5.  Role of Glycation in Type 2 Diabetes Mellitus and Its Prevention through Nymphaea Species.

Authors:  Nayab Ishrat; Hamda Khan; Om P S Patel; Abbas Ali Mahdi; Farina Mujeeb; Saheem Ahmad
Journal:  Biomed Res Int       Date:  2021-10-27       Impact factor: 3.411

6.  Structural alterations of human serum albumin caused by glycative and oxidative stressors revealed by circular dichroism analysis.

Authors:  Fiammetta Monacelli; Daniela Storace; Cristina D'Arrigo; Roberta Sanguineti; Roberta Borghi; Davide Pacini; Anna L Furfaro; Maria A Pronzato; Patrizio Odetti; Nicola Traverso
Journal:  Int J Mol Sci       Date:  2013-05-23       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.